Orlando Magic · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 5.3 | 3.7 | 0.3 | 0.0 | 4.0 | 1.0 | 0.0 | 0.0 | 1.7 | 2.0 |
| 83.3% |
| 0.0 |
| 0.3 |
| 0.0% |
| 0.3 |
| 0.7 |
| 50.0% |
| Last 5 | 5 | 5.1 | 3.0 | 0.6 | 0.2 | 3.8 | 0.6 | 0.0 | 0.2 | 1.2 | 2.0 | 60.0% | 0.0 | 0.2 | 0.0% | 0.6 | 1.2 | 50.0% |
| Last 10 | 10 | 8.0 | 3.7 | 1.0 | 0.7 | 5.4 | 0.6 | 0.0 | 0.1 | 1.1 | 1.7 | 64.7% | 0.3 | 0.8 | 37.5% | 0.6 | 0.9 | 66.7% |
| Last 20 | 20 | 9.5 | 2.8 | 0.8 | 0.8 | 4.4 | 0.6 | 0.0 | 0.2 | 0.7 | 1.3 | 53.8% | 0.3 | 1.1 | 27.3% | 0.5 | 0.7 | 69.2% |
| Season | 54 | 10.9 | 4.4 | 1.2 | 1.1 | 6.7 | 0.4 | 0.0 | 0.5 | 1.1 | 2.0 | 56.0% | 0.5 | 1.5 | 35.4% | 0.6 | 0.9 | 71.7% |
high off-ball shooting, low offensive rebounding, low assist rate, low rim finishing off the ball
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-10 | ORL @ CHI | W | 6.0 | 8 | 0 | 0 | 3 | 0 | 0 | 4 | 5 | 80.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2026-04-08 | ORL vs. MIN | W | 4.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -8.0 |
| 2026-04-06 | ORL vs. DET | W | 5.7 | 3 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -9.0 |
| 2026-04-03 | ORL @ DAL | W | 2.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -1.0 |
| 2026-04-01 | ORL vs. ATL | L | 7.5 | 4 | 2 | 1 | 0 | 0 | 1 | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 2 | 4 | 50.0% | -8.0 |
| 2026-03-29 | ORL @ TOR | L | 18.1 | 0 | 4 | 3 | 0 | 0 | 0 | 0 | 3 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -22.0 |
| 2026-03-26 | ORL vs. SAC | W | 5.2 | 5 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 100.0% | 1 | 1 | 100.0% | 2 | 2 | 100.0% | 4.0 |
| 2026-03-23 | ORL vs. IND | L | 18.5 | 9 | 1 | 3 | 0 | 0 | 0 | 4 | 5 | 80.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 5.0 |
| 2026-03-19 | ORL @ CHA | L | 7.4 | 2 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 5.0 |
| 2026-03-16 | ORL @ ATL | L | 5.5 | 6 | 0 | 0 | 2 | 0 | 0 | 2 | 4 | 50.0% | 1 | 2 | 50.0% | 1 | 1 | 100.0% | 8.0 |
| 2026-03-03 | ORL vs. WAS | W | 13.0 | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 3 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2026-03-01 | ORL vs. DET | L | 3.0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2026-02-24 | ORL @ LAL | W | 5.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2026-02-22 | ORL @ LAC | W | 10.0 | 4 | 1 | 2 | 0 | 0 | 0 | 2 | 3 | 66.7% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2026-02-19 | ORL @ SAC | W | 4.9 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 10.0 |
| 2026-02-11 | ORL vs. MIL | L | 6.8 | 3 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 100.0% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0.0 |
| 2026-02-09 | ORL vs. MIL | W | 17.1 | 5 | 3 | 0 | 0 | 0 | 1 | 2 | 6 | 33.3% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 14.0 |
| 2026-02-07 | ORL vs. UTA | W | 13.6 | 5 | 0 | 2 | 1 | 0 | 0 | 1 | 1 | 100.0% | 1 | 1 | 100.0% | 2 | 2 | 100.0% | -10.0 |
| 2026-02-05 | ORL vs. BKN | W | 22.5 | 1 | 1 | 2 | 2 | 0 | 0 | 0 | 4 | 0.0% | 0 | 3 | 0.0% | 1 | 2 | 50.0% | 6.0 |
| 2026-02-03 | ORL @ OKC | L | 12.9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -13.0 |
| 2026-02-01 | ORL @ SAS | L | 2.2 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 1 | 1 | 100.0% | 8.0 |
| 2026-01-28 | ORL @ MIA | W | 1.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 4.0 |
| 2026-01-26 | ORL @ CLE | L | 4.7 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -7.0 |
| 2026-01-24 | ORL vs. CLE | L | 15.1 | 4 | 1 | 2 | 0 | 0 | 1 | 1 | 4 | 25.0% | 0 | 3 | 0.0% | 2 | 2 | 100.0% | -4.0 |
| 2026-01-22 | ORL vs. CHA | L | 23.5 | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 5 | 20.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -15.0 |
| 2026-01-18 | ORL @ MEM | L | 20.5 | 11 | 4 | 3 | 0 | 0 | 1 | 5 | 8 | 62.5% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 7.0 |
| 2026-01-11 | ORL vs. NOP | W | 7.3 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 33.3% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -11.0 |
| 2026-01-09 | ORL vs. PHI | L | 18.5 | 9 | 3 | 0 | 0 | 1 | 0 | 4 | 6 | 66.7% | 0 | 0 | 0.0% | 1 | 4 | 25.0% | -14.0 |
| 2026-01-06 | ORL @ WAS | L | 25.7 | 20 | 3 | 3 | 0 | 0 | 2 | 7 | 12 | 58.3% | 3 | 4 | 75.0% | 3 | 3 | 100.0% | 17.0 |
| 2026-01-04 | ORL vs. IND | W | 26.9 | 12 | 1 | 4 | 0 | 0 | 0 | 5 | 9 | 55.6% | 2 | 5 | 40.0% | 0 | 1 | 0.0% | 14.0 |
| 2026-01-02 | ORL @ CHI | L | 7.6 | 7 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 66.7% | 1 | 1 | 100.0% | 2 | 2 | 100.0% | -10.0 |
| 2025-12-31 | ORL @ IND | W | 7.8 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2025-12-29 | ORL @ TOR | L | 19.7 | 7 | 3 | 4 | 1 | 0 | 0 | 2 | 7 | 28.6% | 1 | 4 | 25.0% | 2 | 2 | 100.0% | 12.0 |
| 2025-12-27 | ORL vs. DEN | W | 17.4 | 4 | 3 | 1 | 1 | 0 | 1 | 1 | 4 | 25.0% | 0 | 3 | 0.0% | 2 | 3 | 66.7% | 15.0 |
| 2025-12-26 | ORL vs. CHA | L | 22.1 | 14 | 4 | 2 | 0 | 0 | 0 | 5 | 7 | 71.4% | 1 | 2 | 50.0% | 3 | 4 | 75.0% | -4.0 |
| 2025-12-23 | ORL @ POR | W | 11.6 | 2 | 2 | 2 | 0 | 0 | 1 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -8.0 |
| 2025-12-22 | ORL @ GSW | L | 22.0 | 11 | 4 | 0 | 1 | 1 | 3 | 5 | 11 | 45.5% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | -21.0 |
| 2025-12-20 | ORL @ UTA | W | 23.2 | 10 | 1 | 3 | 0 | 0 | 1 | 4 | 10 | 40.0% | 2 | 5 | 40.0% | 0 | 0 | 0.0% | 8.0 |
| 2025-12-18 | ORL @ DEN | L | 19.3 | 9 | 1 | 2 | 1 | 0 | 2 | 4 | 9 | 44.4% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 1.0 |
| 2025-12-13 | ORL @ NYK | L | 7.6 | 9 | 1 | 2 | 0 | 0 | 0 | 3 | 4 | 75.0% | 2 | 3 | 66.7% | 1 | 2 | 50.0% | -2.0 |
| 2025-12-07 | ORL @ NYK | L | 5.7 | 8 | 1 | 0 | 1 | 0 | 0 | 3 | 6 | 50.0% | 1 | 3 | 33.3% | 1 | 2 | 50.0% | 6.0 |
| 2025-12-05 | ORL vs. MIA | W | 3.9 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2025-12-03 | ORL vs. SAS | L | 15.9 | 8 | 5 | 2 | 1 | 0 | 0 | 3 | 5 | 60.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 9.0 |
| 2025-11-25 | ORL @ PHI | W | 10.0 | 7 | 0 | 1 | 1 | 0 | 1 | 2 | 5 | 40.0% | 1 | 2 | 50.0% | 2 | 2 | 100.0% | 3.0 |
| 2025-11-23 | ORL @ BOS | L | 21.3 | 18 | 5 | 2 | 0 | 0 | 0 | 7 | 11 | 63.6% | 3 | 4 | 75.0% | 1 | 1 | 100.0% | 8.0 |
| 2025-11-22 | ORL vs. NYK | W | 1.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2025-11-20 | ORL vs. LAC | W | 4.8 | 3 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 100.0% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 10.0 |
| 2025-11-12 | ORL @ NYK | W | 1.9 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2025-11-04 | ORL @ ATL | L | 7.1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -1.0 |
| 2025-11-01 | ORL @ WAS | W | 6.0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 9.0 |
| 2025-10-30 | ORL @ CHA | W | 1.9 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2025-10-29 | ORL @ DET | L | 3.7 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -1.0 |
| 2025-10-27 | ORL @ PHI | L | 0.9 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2025-10-25 | ORL vs. CHI | L | 8.2 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 33.3% | 0 | 2 | 0.0% | 1 | 2 | 50.0% | -5.0 |